Hippocampal glutamate-glutamine (Glx) in adults with Down syndrome: a preliminary study using in vivo proton magnetic resonance spectroscopy (1H MRS)

被引:0
作者
Giles MY Tan
Felix Beacher
Eileen Daly
Jamie Horder
Verinder Prasher
Maria-Luisa Hanney
Robin Morris
Simon Lovestone
Kieran C Murphy
Andrew Simmons
Declan GM Murphy
机构
[1] Institute of Psychiatry,Sackler Institute for Translational Neurodevelopment, Department of Forensic and Neurodevelopmental Sciences
[2] King’s College London,Southern Health NHS Foundation Trust
[3] North Hampshire Community Learning Disability Service,Northumberland Tyne and Wear NHS Foundation Trust
[4] Greenfields Monyhull Hospital,Department of Psychology, Institute of Psychiatry
[5] Northgate Hospital,Department of Old Age Psychiatry, Institute of Psychiatry
[6] King’s College London,Department of Psychiatry
[7] King’s College London,Department of Neuroimaging, Institute of Psychiatry
[8] Royal College of Surgeons in Ireland,NIHR Biomedical Research Centre for Mental Health and Biomedical Research Unit for Dementia
[9] King’s College London,undefined
[10] South London and Maudsley NHS Foundation Trust,undefined
来源
Journal of Neurodevelopmental Disorders | 2014年 / 6卷
关键词
Down syndrome; Intellectual disability; Alzheimer’s disease; Dementia; Magnetic resonance spectroscopy; H MRS; Hippocampus; Glutamate-glutamine (Glx);
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 405 条
[1]  
Wisniewski KE(1990)Down syndrome children often have brain with maturation delay, retardation of growth, and cortical dysgenesis Am J Med Genet Suppl 7 274-281
[2]  
Schupf N(2002)Genetic and host factors for dementia in Down’s syndrome Br J Psychiatry 180 405-410
[3]  
Sergievsky GH(1997)Prospective study of the prevalence of Alzheimer-type dementia in institutionalized individuals with Down syndrome Am J Ment Retard 101 400-412
[4]  
Visser FE(2007)Fifteen-year follow-up of 92 hospitalized adults with Down’s syndrome: incidence of cognitive decline, its relationship to age and neuropathology J Intellect Disabil Res 51 463-477
[5]  
Aldenkamp AP(2014)Dementia in intellectual disability Curr Opin Psychiatry 27 143-148
[6]  
van Huffelen AC(1998)Molecular mapping of Alzheimer-type dementia in Down’s syndrome Ann Neurol 43 380-383
[7]  
Kuilman M(2007)Fetal Down syndrome brains exhibit aberrant levels of neurotransmitters critical for normal brain development Pediatrics 120 e1465-e1471
[8]  
Overweg J(2010)Early pharmacotherapy restores neurogenesis and cognitive performance in the Ts65Dn mouse model for Down syndrome J Neurosci 30 8769-8779
[9]  
van Wijk J(2004)Synaptic structural abnormalities in the Ts65Dn mouse model of Down syndrome J Comp Neurol 480 281-298
[10]  
Margallo-Lana ML(2005)Hippocampal myo-inositol and cognitive ability in adults with Down syndrome: an Arch Gen Psychiatry 62 1360-1365